NewsRx

Search our medical news database

Vaccines

Jerald C. Sadoff, MD Joins NanoBio Scientific Advisory Board

Published in Hepatitis Weekly, July 30th, 2007

NanoBio(R) Corporation, a biopharmaceutical company developing novel anti-infectives and mucosal vaccines to treat and prevent serious infections, announced that Jerald C. Sadoff, MD, has joined the NanoBio Scientific Advisory Board. Sadoff will assist NanoBio in developing and commercializing its novel vaccines for hepatitis B, influenza and other debilitating conditions. The company's patented NanoStat technology serves as a delivery system for its mucosal vaccine candidates, while simultaneously adjuvanting and thermally stabilizing the associated antigen.

"Dr. Sadoff brings with him three decades of extensive experience developing vaccines for dozens of diseases,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook